Rankings
▼
Calendar
RAPT (RAPT Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
RAPT
RAPT Therapeutics, Inc.
Mkt Cap
$959M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$106M
EPS (TTM)
-$11.07
Free Cash Flow (TTM)
-$87M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$0
$0
-$24M
Q1 23
$0
$0
-$32M
Q2 23
$0
$0
-$28M
Q3 23
$0
$0
-$34M
Q4 23
$0
$0
-$33M
Q1 24
$0
-$314K
-$33M
Q2 24
$0
$0
-$29M
Q3 24
$0
$0
-$20M
Q4 24
$0
$0
-$54M
Q1 25
$0
$0
-$19M
Q2 25
$0
-$200K
-$20M
Q3 25
$0
$0
-$19M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
628.2x
—
Q1 23
1082.7x
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
—
—
Q3 24
—
—
Q4 24
—
—
Q1 25
—
—
Q2 25
—
—
Q3 25
—
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$23M
-$23M
Q1 23
-$19M
-$19M
Q2 23
-$29M
-$29M
Q3 23
-$22M
-$22M
Q4 23
-$28M
-$28M
Q1 24
-$27M
-$27M
Q2 24
-$28M
-$28M
Q3 24
-$18M
-$18M
Q4 24
-$10M
-$10M
Q1 25
-$52M
-$52M
Q2 25
-$11M
-$11M
Q3 25
-$12M
-$12M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$49K
Q1 23
$759K
Q2 23
$233K
Q3 23
$66K
Q4 23
$67K
Q1 24
$105K
Q2 24
$1K
Q3 24
$17K
Q4 24
$1K
Q1 25
$43K
Q2 25
$40K
Q3 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
-100.0%
+30.0%
Q1 23
-100.0%
+47.4%
Q2 23
-100.0%
+43.3%
Q3 23
—
+56.5%
Q4 23
—
+36.0%
Q1 24
—
+3.0%
Q2 24
—
+3.4%
Q3 24
—
-41.7%
Q4 24
—
+64.0%
Q1 25
—
-40.8%
Q2 25
—
-33.4%
Q3 25
—
-2.1%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$3M
—
Q1 23
$0
—
Q2 23
$4M
—
Q3 23
$0
—
Q4 23
$4M
—
Q1 24
$5M
—
Q2 24
$5M
—
Q3 24
$5M
—
Q4 24
$5M
—
Q1 25
$5M
—
Q2 25
$5M
—
Q3 25
$5M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q4 22
$19M
$5M
Q1 23
$26M
$6M
Q2 23
$22M
$7M
Q3 23
$27M
$7M
Q4 23
$27M
$6M
Q1 24
$25M
$8M
Q2 24
$23M
$7M
Q3 24
$13M
$6M
Q4 24
$46M
$8M
Q1 25
$12M
$7M
Q2 25
$12M
$7M
Q3 25
$12M
$7M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$39M
$210M
$249M
Q1 23
$46M
$186M
$232M
Q2 23
$50M
$155M
$205M
Q3 23
$54M
$131M
$185M
Q4 23
$47M
$111M
$159M
Q1 24
$45M
$96M
$142M
Q2 24
$37M
$78M
$115M
Q3 24
$38M
$60M
$98M
Q4 24
$170M
$61M
$231M
Q1 25
$60M
$119M
$179M
Q2 25
$42M
$127M
$169M
Q3 25
$38M
$119M
$157M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
4M
+6.0%
Q1 23
5M
+7.3%
Q2 23
5M
+0.1%
Q3 23
5M
+0.1%
Q4 23
5M
+0.1%
Q1 24
5M
+0.6%
Q2 24
5M
+0.6%
Q3 24
5M
+0.1%
Q4 24
6M
+20.0%
Q1 25
27M
+361.4%
Q2 25
27M
+0.1%
Q3 25
27M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 17
—
—
FY 18
—
—
FY 19
$0
67
FY 20
$74K
68
FY 21
$47K
81
FY 22
$16K
97
FY 23
$0
131
FY 24
$0
68
marketcaparena.com